PANACEA LIFE SCIENCES HOLDINGS, INC. Quarterly Debt-to-equity in % from Q1 2016 to Q1 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Panacea Life Sciences Holdings, Inc. quarterly Debt-to-equity history and growth rate from Q1 2016 to Q1 2024.
  • Panacea Life Sciences Holdings, Inc. Debt-to-equity for the quarter ending March 31, 2024 was -343 %, a 83.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 -343 +1.69K +83.1% Mar 31, 2024
Q4 2023 -408 -2.49K -120% Dec 31, 2023
Q3 2023 -524 -1.1K -191% Sep 30, 2023
Q2 2023 -735 -1.06K -329% Jun 30, 2023
Q1 2023 -2.04K -2.25K -1062% Mar 31, 2023
Q4 2022 2.08K +1.93K +1278% Dec 31, 2022
Q3 2022 573 +397 +225% Sep 30, 2022
Q2 2022 321 +170 +112% Jun 30, 2022
Q1 2022 212 +88.2 +71.4% Mar 31, 2022
Q4 2021 151 +33.7 +28.8% Dec 31, 2021
Q3 2021 176 +127 +258% Sep 30, 2021
Q2 2021 151 +111 +271% Jun 30, 2021
Q1 2021 124 +84.1 +213% Mar 31, 2021
Q4 2020 117 +73.2 +167% Dec 31, 2020
Q3 2020 49.2 -48.1 -49.4% Sep 30, 2020
Q2 2020 40.8 +2.56K Jun 30, 2020
Q1 2020 39.5 +216 Mar 31, 2020
Q4 2019 43.9 +145 Dec 31, 2019
Q3 2019 97.2 +200 Sep 30, 2019
Q2 2019 -2.52K -2.4K -2036% Jun 30, 2019
Q1 2019 -177 -23.4 -15.3% Mar 31, 2019
Q4 2018 -102 +313 +75.5% Dec 31, 2018
Q3 2018 -103 -225 -184% Sep 30, 2018
Q2 2018 -118 -180 -288% Jun 30, 2018
Q1 2018 -153 -197 -454% Mar 31, 2018
Q4 2017 -414 -459 -1021% Dec 31, 2017
Q3 2017 122 +59.9 +96.4% Sep 30, 2017
Q2 2017 62.6 -11.1 -15.1% Jun 30, 2017
Q1 2017 43.4 +2.73K Mar 31, 2017
Q4 2016 45 Dec 31, 2016
Q3 2016 62.1 Sep 30, 2016
Q2 2016 73.7 Jun 30, 2016
Q1 2016 -2.68K Mar 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.